£32k
+1%vs Sept 2023Active12195179Private limited companyLondon
PHARMEDAS CLINICAL LTD
Significant control: Ado Hadejia Muhammad (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Pharmedas Clinical Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Pharmedas Clinical Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
PHARMEDAS CLINICAL LTD is an active private limited company (company number 12195179) incorporated on 9 September 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest abridged accounts cover the period ending 30 September 2024, showing net assets of £32k and cash of £30k, with 2 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 1% on the prior period (£32k).
Peer position · net assets
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr Ado Hadejia Muhammad
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 9 September 20197 yrs ago
- Next accounts due
- 30 June 2026118 days overdue
- Confirmation statement due
- 23 September 2027in 332 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 86900
- Other human health activities
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£30k
−32%vs Sept 2023Not disclosed
2
vs Sept 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2024 | £32k | £30k | £24k | £22k | — | — | 2 |
| 30 September 2023 | £32k | £45k | £2,676 | £16k | — | — | 0 |
Current ratio2.44Current assets ÷ creditors within one year
Cash per employee£15kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £31,931 at 30 September 2024
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.44
- Incorporated five or more years agoIncorporated 9 September 2019
- Accounts past their due dateDue 30 June 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 332 days
- Next accounts due118 days overdue
- Accounts period endNet assets £32k · abridged accounts
- Accounts period endNet assets £32k · abridged accounts
- Incorporated
08
Similar companies in London
- MOLECULES TO MEDICINES LTDLondon · inc. Sept 2019
- RESEARCH CONSULTANCY AND HEALTH LTDLondon · inc. Sept 2019
- SENZO HEALTH LIMITEDLondon · inc. Aug 2019
- OXILIO LIMITEDLondon · inc. Aug 2019
- CELLINTA LTDLondon · inc. Aug 2019
- ALCHEMAB THERAPEUTICS LTDLondon · inc. Aug 2019
All companies incorporated on 9 September 2019 · in Sept 2019.
09
Reminders for PHARMEDAS CLINICAL LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.